PHILADELPHIA, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Notice is hereby given that Barrack, Rodos & Bacine has filed a class action lawsuit in the United States District Court for the Eastern District of Pennsylvania, Case No. 2:18-cv-00323-RK, on behalf of investors who hold common stock of Aetna, Inc. (“Aetna” or the “Company”) (NYSE:AET), for alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the proposed sale of the Company to CVS Health Corporation.
The complaint alleges that the Form S-4 filed with the U.S. Securities and Exchange Commission on January 4, 2018 and disseminated to Aetna stockholders contains materially incomplete and misleading information concerning the background of the Proposed Transaction, the Aetna Board’s recommendation, and key inputs and assumptions used by Aetna’s financial advisors in providing their fairness opinions with regard to the Proposed Transaction. The complaint further alleges that without this information, Aetna’s stockholders cannot make an informed decision on whether to vote their shares in favor of the Proposed Transaction.
If you wish to serve as lead plaintiff, you must move the Court no later than March 19, 2018. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you are a current Aetna stockholder and wish to discuss your rights, please contact Barrack Rodos & Bacine at the following toll-free number: 877-386-3304, or via e-mail to Julie B. Palley (jpalley@barrack.com). Barrack Rodos & Bacine has four decades of experience prosecuting stockholder securities class actions and derivative actions and has achieved some of the largest recoveries in the history of such litigation.